Back to top
more

Teleflex (TFX)

(Delayed Data from NYSE)

$206.64 USD

206.64
884,665

+4.13 (2.04%)

Updated May 30, 2024 04:00 PM ET

After-Market: $206.45 -0.19 (-0.09%) 7:30 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (148 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Teleflex COMFORT FLO System's Voluntary Recall Ranked Class I

Teleflex's (TFX) COMFORT FLO Humidification System up for worldwide voluntary recall after the receipt of complaints of device malfunction.

Teleflex's Bipolar Temporary Pacing Guidewire Gets FDA Nod

Teleflex (TFX) receives the FDA clearance for its bipolar temporary pacing guidewire, thus paving the way for improvements in TAVR and BAV procedures.

Teleflex (TFX) Receives FDA Nod for Expanded Use of UroLift

Teleflex (TFX) receives FDA clearance for expanded indication for the utilization of the UroLift System for treating larger prostrates in men.

Here's Why You Should Hold on to Teleflex (TFX) Stock for Now

Investors continue to be optimistic about Teleflex (TFX) on its strong segmental and international performance in Q3.

Teleflex Hits New 52-Week High: What's Driving the Rally?

Teleflex (TFX) is optimistic about maintaining growth momentum on several recent developments.

Teleflex (TFX) Earnings and Revenues Beat Estimates in Q3

We are encouraged by Teleflex's (TFX) robust improvement in Q3 revenues on balanced growth across majority of segments and all geographies.

Teleflex (TFX) Tops Q3 Earnings and Revenue Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 8.00% and 0.78%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More

Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.

Teleflex (TFX) Earnings Expected to Grow: Should You Buy?

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Hold on to Teleflex (TFX) Stock Now

Investor confidence is still high on Teleflex (TFX), thanks to solid prospects.

Teleflex (TFX) Up 0.7% Since Last Earnings Report: Can It Continue?

Teleflex (TFX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Teleflex (TFX) Q2 Earnings Top Estimates, Margins Improve

Teleflex (TFX) sees robust revenue improvement across majority of segments and all geographies.

Teleflex (TFX) Q2 Earnings Top Estimates, Margins Improve

Teleflex (TFX) sees robust revenue improvement across majority of segments and all geographies.

Teleflex (TFX) Surpasses Q2 Earnings and Revenue Estimates

Teleflex (TFX) delivered earnings and revenue surprises of 2.70% and 2.48%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Illumina (ILMN) Q2 Earnings Beat Estimates, Margins Contract

Illumina's (ILMN) witnessed top-line growth across its high and low throughput categories in the second quarter of 2019.

GNC Holdings (GNC) Q2 Earnings Beat Estimates, Margins Expand

GNC Holdings' (GNC) Q2 revenues decline year over year at each of the three operating segments.

Zimmer Biomet (ZBH) Beats on Q2 Earnings, Narrows '19 View

Zimmer Biomet (ZBH) observes strength in the Asia Pacific and EMEA regions as well as in the S.E.T. business.

Omnicell (OMCL) Beats on Earnings in Q2, Tapers '19 EPS View

Omnicell (OMCL) aims at product innovation through R&D.

Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates

Higher revenues, solid segmental performance and strong organic growth across businesses benefit Stryker's (SYK) Q2 earnings.

Merit Medical (MMSI) Q2 Earnings & Revenues Miss Estimates

Higher revenues and solid segmental performance margins benefit Merit Medical's (MMSI) Q2 earnings. However, contraction in both gross and operating margins remains a concern.

Chemed (CHE) Earnings Top Estimates in Q2, Margins Expand

It is encouraging to note that Chemed (CHE) witnessed solid revenue growth across both of its key subsidiaries.

ResMed's (RMD) Q4 Earnings Beat Estimates, Margins Expand

ResMed (RMD) achieves double-digit global revenue growth in the fourth quarter, led by strong sales at Software-as-a-Service businesses as well as of new mask products and devices.

LabCorp's (LH) Q2 Earnings Beat Estimates, Margins Fall

While rising acquisitions and a favorable mix contribute to LabCorp's (LH) Diagnostics business, the disposition of certain businesses and the implementation of PAMA dented the company's growth in Q2.

Teleflex (TFX) Earnings Expected to Grow: Should You Buy?

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Align Technology (ALGN) Beats on Q2 Earnings, Margins Fall

We are upbeat about Align Technology's (ALGN) continued momentum in Invisalign volumes across all geographies.